PT1265914E - Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos - Google Patents
Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos Download PDFInfo
- Publication number
- PT1265914E PT1265914E PT01920759T PT01920759T PT1265914E PT 1265914 E PT1265914 E PT 1265914E PT 01920759 T PT01920759 T PT 01920759T PT 01920759 T PT01920759 T PT 01920759T PT 1265914 E PT1265914 E PT 1265914E
- Authority
- PT
- Portugal
- Prior art keywords
- wnt
- same
- nucleic acids
- acids encoding
- related polypeptides
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 101100156752 Caenorhabditis elegans cwn-1 gene Proteins 0.000 title 1
- 102000052547 Wnt-1 Human genes 0.000 title 1
- 108700020987 Wnt-1 Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19125800P | 2000-03-22 | 2000-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1265914E true PT1265914E (pt) | 2008-04-08 |
Family
ID=38885296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01920759T PT1265914E (pt) | 2000-03-22 | 2001-03-22 | Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20020098540A1 (pt) |
| EP (1) | EP1265914B1 (pt) |
| JP (1) | JP2003527849A (pt) |
| AT (1) | ATE382055T1 (pt) |
| AU (2) | AU2001247781C1 (pt) |
| CA (1) | CA2404216A1 (pt) |
| DE (1) | DE60132075T2 (pt) |
| DK (1) | DK1265914T3 (pt) |
| ES (1) | ES2298226T3 (pt) |
| PT (1) | PT1265914E (pt) |
| WO (1) | WO2001070775A2 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0114644D0 (en) * | 2001-06-15 | 2001-08-08 | Oxford Glycosciences Uk Ltd | Protein |
| EP1500665B1 (en) | 2002-04-15 | 2011-06-15 | Chugai Seiyaku Kabushiki Kaisha | METHODS FOR CONSTRUCTING scDb LIBRARIES |
| WO2004065611A1 (ja) | 2003-01-21 | 2004-08-05 | Chugai Seiyaku Kabushiki Kaisha | 抗体の軽鎖スクリーニング方法 |
| WO2005042582A1 (ja) * | 2003-11-04 | 2005-05-12 | Chugai Seiyaku Kabushiki Kaisha | 抗体の製造方法 |
| JP4794301B2 (ja) | 2003-06-11 | 2011-10-19 | 中外製薬株式会社 | 抗体の製造方法 |
| US20050251054A1 (en) * | 2004-05-10 | 2005-11-10 | Medpond, Llc | Method and apparatus for measurement of autonomic nervous system function |
| JP5620626B2 (ja) | 2005-03-31 | 2014-11-05 | 中外製薬株式会社 | 会合制御によるポリペプチド製造方法 |
| WO2006106903A1 (ja) | 2005-03-31 | 2006-10-12 | Chugai Seiyaku Kabushiki Kaisha | sc(Fv)2構造異性体 |
| JP5085322B2 (ja) | 2005-06-10 | 2012-11-28 | 中外製薬株式会社 | ｓｃ（Ｆｖ）２を含有する医薬組成物 |
| JP5068167B2 (ja) | 2005-06-10 | 2012-11-07 | 中外製薬株式会社 | メグルミンを含有するタンパク質製剤の安定化剤、およびその利用 |
| EP3345616A1 (en) | 2006-03-31 | 2018-07-11 | Chugai Seiyaku Kabushiki Kaisha | Antibody modification method for purifying bispecific antibody |
| WO2010004273A1 (en) | 2008-07-07 | 2010-01-14 | Oxford Nanopore Technologies Limited | Base-detecting pore |
| US20110229877A1 (en) | 2008-07-07 | 2011-09-22 | Oxford Nanopore Technologies Limited | Enzyme-pore constructs |
| GB0820927D0 (en) | 2008-11-14 | 2008-12-24 | Isis Innovation | Method |
| CN102482330A (zh) * | 2009-01-30 | 2012-05-30 | 牛津纳米孔技术有限公司 | 酶突变体 |
| EP2391732B1 (en) | 2009-01-30 | 2015-05-27 | Oxford Nanopore Technologies Limited | Methods using adaptors for nucleic acid constructs in transmembrane sequencing |
| GB0905140D0 (en) | 2009-03-25 | 2009-05-06 | Isis Innovation | Method |
| BR112013020411B1 (pt) | 2011-02-11 | 2021-09-08 | Oxford Nanopore Technologies Limited | Monômero de msp mutante, construto, polinucleotídeo, poro, kit e aparelho para caracterizar uma sequência de ácido nucleico alvo, e, método para caracterizar uma sequência de ácido nucleico alvo |
| KR20140050067A (ko) | 2011-07-25 | 2014-04-28 | 옥스포드 나노포어 테크놀로지즈 리미티드 | 막횡단 포어를 사용한 이중 가닥 폴리뉴클레오티드 서열분석을 위한 헤어핀 루프 방법 |
| US9777049B2 (en) | 2012-04-10 | 2017-10-03 | Oxford Nanopore Technologies Ltd. | Mutant lysenin pores |
| US11155860B2 (en) | 2012-07-19 | 2021-10-26 | Oxford Nanopore Technologies Ltd. | SSB method |
| EP2964779B1 (en) | 2013-03-08 | 2018-08-29 | Oxford Nanopore Technologies Limited | Use of spacer elements in a nucleic acid to control movement of a helicase |
| GB201314695D0 (en) | 2013-08-16 | 2013-10-02 | Oxford Nanopore Tech Ltd | Method |
| GB201313477D0 (en) | 2013-07-29 | 2013-09-11 | Univ Leuven Kath | Nanopore biosensors for detection of proteins and nucleic acids |
| SG11201602261VA (en) | 2013-09-27 | 2016-04-28 | Chugai Pharmaceutical Co Ltd | Method for producing polypeptide heteromultimer |
| GB201403096D0 (en) | 2014-02-21 | 2014-04-09 | Oxford Nanopore Tech Ltd | Sample preparation method |
| EP3137627A1 (en) | 2014-05-02 | 2017-03-08 | Oxford Nanopore Technologies Limited | Method of improving the movement of a target polynucleotide with respect to a transmembrane pore |
| JP7161291B2 (ja) | 2014-09-01 | 2022-10-26 | ブイアイビー ブイゼットダブリュ | 変異体ポア |
| WO2016055778A1 (en) | 2014-10-07 | 2016-04-14 | Oxford Nanopore Technologies Limited | Mutant pores |
| GB201418159D0 (en) | 2014-10-14 | 2014-11-26 | Oxford Nanopore Tech Ltd | Method |
| SG11201803989WA (en) | 2015-12-28 | 2018-06-28 | Chugai Pharmaceutical Co Ltd | Method for promoting efficiency of purification of fc region-containing polypeptide |
| GB201609220D0 (en) | 2016-05-25 | 2016-07-06 | Oxford Nanopore Tech Ltd | Method |
| GB201807793D0 (en) | 2018-05-14 | 2018-06-27 | Oxford Nanopore Tech Ltd | Method |
| CN114457052B (zh) * | 2021-09-17 | 2024-02-27 | 厦门大学 | 一种抗肿瘤的多肽组合物及其应用 |
-
2001
- 2001-03-22 AU AU2001247781A patent/AU2001247781C1/en not_active Ceased
- 2001-03-22 AT AT01920759T patent/ATE382055T1/de active
- 2001-03-22 JP JP2001568976A patent/JP2003527849A/ja active Pending
- 2001-03-22 US US09/815,248 patent/US20020098540A1/en not_active Abandoned
- 2001-03-22 PT PT01920759T patent/PT1265914E/pt unknown
- 2001-03-22 DE DE60132075T patent/DE60132075T2/de not_active Expired - Lifetime
- 2001-03-22 EP EP01920759A patent/EP1265914B1/en not_active Expired - Lifetime
- 2001-03-22 ES ES01920759T patent/ES2298226T3/es not_active Expired - Lifetime
- 2001-03-22 AU AU4778101A patent/AU4778101A/xx active Pending
- 2001-03-22 DK DK01920759T patent/DK1265914T3/da active
- 2001-03-22 CA CA002404216A patent/CA2404216A1/en not_active Abandoned
- 2001-03-22 WO PCT/US2001/009600 patent/WO2001070775A2/en active IP Right Grant
-
2003
- 2003-04-24 US US10/422,335 patent/US20050159373A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/931,835 patent/US20080206252A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK1265914T3 (da) | 2008-03-10 |
| DE60132075T2 (de) | 2009-03-12 |
| WO2001070775A3 (en) | 2002-01-10 |
| DE60132075D1 (de) | 2008-02-07 |
| EP1265914A2 (en) | 2002-12-18 |
| ES2298226T3 (es) | 2008-05-16 |
| AU4778101A (en) | 2001-10-03 |
| JP2003527849A (ja) | 2003-09-24 |
| AU2001247781C1 (en) | 2006-08-17 |
| CA2404216A1 (en) | 2001-09-27 |
| ATE382055T1 (de) | 2008-01-15 |
| EP1265914B1 (en) | 2007-12-26 |
| WO2001070775A2 (en) | 2001-09-27 |
| AU2001247781B2 (en) | 2006-02-02 |
| US20080206252A1 (en) | 2008-08-28 |
| US20050159373A1 (en) | 2005-07-21 |
| US20020098540A1 (en) | 2002-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1265914E (pt) | Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos | |
| NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
| HK1013847A1 (en) | Gdf-1 and uog-1 proteins | |
| ATE368053T1 (de) | Antimikrobielle peptide | |
| NZ335485A (en) | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | |
| GB9823897D0 (en) | Immunotherapeutic methods and molecules | |
| EP0258411A4 (en) | DNA ENCODING STREPTAVIDINE, STREPTAVIDINE PRODUCED FROM IT, FUSED POLYPEPTIDES WITH AMINO ACID SEQUENCES FROM STREPTAVIDINE AND USES. | |
| WO2002016418A3 (en) | An iap binding peptide or polypeptide and methods of using the same | |
| WO2002101052A3 (en) | Salutaridinol 7-o-acetyltransferase and derivatives thereof | |
| WO2003016342A3 (en) | Tumor antigens for prevention and/or treatment of cancer | |
| DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
| GB9416536D0 (en) | Orphan receptor | |
| WO2001098355A3 (en) | Cgi-69 compositions and methods of use | |
| WO2001070808A3 (en) | Angiogenesis - associated proteins, and nucleic acids encoding the same | |
| WO1999031229A3 (en) | Peptides and nucleic acids derived from eisenia foetida and the use thereof | |
| GB2357507A (en) | Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants | |
| EP0723016A3 (en) | Leukocyte activation factor | |
| WO2001049714A3 (en) | Nope polypeptides, encoding nucleic acids and methods of use | |
| DE69831584D1 (de) | Polypeptide mit wasserkanalaktivität und dna sequenzen | |
| ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
| WO1999031256A3 (en) | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis | |
| WO2002097036A3 (en) | Compositions and methods for adipose abundant protein | |
| WO2002096355A3 (en) | Compositions and methods for adipose abundant protein | |
| WO2001060972A3 (en) | Novel peptides and methods of use | |
| HUP0001462A2 (en) | Human toll-like receptor proteins, related reagents and methods |